Surrozen SRZN
NASDAQ SRZN
$32.22 -0.42 (-1.30%)
As of: Nov 11, 2026 · 12:24 PM EST

Surrozen (SRZN) Long-Term Investments (2021 - 2025)

Updated

Surrozen (SRZN) recorded Long-Term Investments of $11.78 million in Q1 2022, down 87.2% from $92.03 million a year earlier and down 45.6% from the prior quarter.

Analysis

Surrozen (SRZN) Long-Term Investments (2021 - 2025) Analysis & Trends

At the end of FY2021, Surrozen reported Long-Term Investments of $21.66 million.

  • Per Business Quant, the preceding three quarters came in at $21.66 million (Q4 2021), $25.26 million (Q3 2021) and $92.03 million (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Surrozen 384.30 Mn -14.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 25.50 Mn
Jun 30, 2025 25,495.00
Mar 31, 2025 25,495.00
Sep 30, 2024 33,014.00
Jun 30, 2024 33.01 Mn
Mar 31, 2024 33,014.00
Sep 30, 2023 9,194.00
Jun 30, 2023 9,194.00
Mar 31, 2023 9.19 Mn
Mar 31, 2022 11.78 Mn
Dec 31, 2021 21.66 Mn
Sep 30, 2021 25.26 Mn
Jun 30, 2021 92.03 Mn
Mar 31, 2021 92.03 Mn
API Access

Surrozen Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=SRZN&period=max&api_key=YOUR_API_KEY